Back to search results

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

IsraelRecruitingPHASE3

Conditions

Ovarian Neoplasms · Ovarian Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Mount Sinai Cancer Center ( Site 0029), Miami Beach, Florida, United States

    Study coordinator · 305-674-2625

  • Parkview Research Center at Parkview Regional Medical Center ( Site 0055), Fort Wayne, Indiana, United States

    Study coordinator · 206-266-7701

  • Women's Cancer Care ( Site 0018), Covington, Louisiana, United States

    Study coordinator · 985-892-2252

  • Nebraska Methodist Hospital ( Site 0004), Omaha, Nebraska, United States

    Study coordinator · 402-354-7939

  • Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0007), Tulsa, Oklahoma, United States

    Study coordinator · 918-505-3200

  • West Cancer Center and Research Institute ( Site 0013), Germantown, Tennessee, United States

    Study coordinator · 901-683-0055

  • Instituto Alexander Fleming ( Site 2902), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

    Study coordinator · 5411 3221 8900

  • Instituto de Investigaciones Clinicas Mar del Plata ( Site 2901), Mar del Plata, Buenos Aires, Argentina

    Study coordinator · +54 223 496 3224

  • Fundación Respirar ( Site 2912), Buenos Aires, Buenos Aires F.D., Argentina

    Study coordinator · +541147815331

  • Sanatorio Parque - Oncología ( Site 2911), Rosario, Santa Fe Province, Argentina

    Study coordinator · +543412987413

  • Instituto de Oncologia de Rosario ( Site 2909), Rosario, Santa Fe Province, Argentina

    Study coordinator · +543414218909

  • Hospital Britanico de Buenos Aires ( Site 2905), CABA, Argentina

    Study coordinator · +5411 4309 4469

  • Fundación CORI para la Investigación y Prevención del Cáncer ( Site 2907), La Rioja, Argentina

    Study coordinator · +54 380 4336443

  • Gallipoli Medical Research Ltd ( Site 0204), Brisbane, Queensland, Australia

    Study coordinator · +61 73394 7296

  • Epworth Freemasons ( Site 0207), East Melbourne, Victoria, Australia

    Study coordinator · +61385595000

  • Medizinische Universitat Wien ( Site 0102), Vienna, State of Vienna, Austria

    Study coordinator · +43 1 4040061030

  • Grand Hopital de Charleroi ( Site 0303), Charleroi, Hainaut, Belgium

    Study coordinator · +3260 11 06 04

  • AZ Maria Middelares ( Site 0302), Ghent, Oost-Vlaanderen, Belgium

    Study coordinator · +32 9 246 95 19

  • UZ Leuven ( Site 0301), Leuven, Vlaams-Brabant, Belgium

    Study coordinator · +32 16 34 74 19

  • Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0414), São José do Rio Preto, São Paulo, Brazil

    Study coordinator · 55 17 32015054

  • Fakultni nemocnice Ostrava-Gynekologicko-porodnicka klinika ( Site 3303), Ostrava-Poruba, Ostrava Mesto, Czechia

    Study coordinator · +420597371804

  • Vseobecna fakultni nemocnice v Praze ( Site 3305), Prague, Czechia

    Study coordinator · +420224967451

  • Fakultni nemocnice motol ( Site 3302), Prague, Czechia

    Study coordinator · +420224431111

  • Herlev Hospital ( Site 0902), Herlev, Capital Region, Denmark

    Study coordinator · +4538689255

  • Aalborg Universitetshospital ( Site 0901), Aalborg, North Denmark, Denmark

    Study coordinator · +4597660000

  • Aarhus Universitetshospital, Skejby ( Site 0903), Aarhus, North Denmark, Denmark

    Study coordinator · +4578450000

  • Oulun yliopistollinen sairaala ( Site 1003), Oulu, North Ostrobothnia, Finland

    Study coordinator · +358 8 3153108

  • Kuopion Yliopistollinen Sairaala ( Site 1004), Kuopio, Northern Savonia, Finland

    Study coordinator · +35844 7176780

  • Tampereen yliopistollinen sairaala ( Site 1002), Tampere, Pirkanmaa, Finland

    Study coordinator · +358331166203

  • Turku University Hospital-Department of Obstetrics and Gynecology ( Site 1001), Turku, Southwest Finland, Finland

    Study coordinator · +358 2 313 0000

  • CENTRE LEON BERARD ( Site 1101), Lyon, Auvergne-Rhône-Alpes, France

    Study coordinator · +33478782888

  • Hôpital Privé Des Côtes d'Armor ( Site 1102), Plérin, Cotes-d Armor, France

    Study coordinator · +33296752216

  • Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne ( Site 1113), Clermont-Ferrand, Puy-de-Dome, France

    Study coordinator · +33473278080

  • Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 3910), Kecskemét, Bács-Kiskun county, Hungary

    Study coordinator · +3676516719

  • Országos Onkológiai Intézet-Ngyógyászat ( Site 3913), Budapest, Hungary

    Study coordinator · +3612248600

  • Debreceni Egyetem Klinikai Kozpont-Szülészeti és Nőgyógyászati Klinika ( Site 3912), Debrecen, Hungary

    Study coordinator · 0652255705

  • Rambam Health Care Campus ( Site 1422), Haifa, Israel

    Study coordinator · +97247772688

  • Edith Wolfson Medical Center ( Site 1423), Holon, Israel

    Study coordinator · +97235028211

  • Gunma Prefectural Cancer Center ( Site 1605), Ōta, Gunma, Japan

    Study coordinator · +81-276-38-0771

  • Hokkaido University Hospital ( Site 1609), Sapporo, Hokkaido, Japan

    Study coordinator · +81-11-716-1161

  • Hyogo Cancer Center ( Site 1620), Akashi, Hyōgo, Japan

    Study coordinator · +81-78-929-1151

  • Iwate Medical University Hospital ( Site 1610), Shiwa-gun, Iwate, Japan

    Study coordinator · +81-19-613-7111

  • Saitama Medical University International Medical Center ( Site 1607), Hidaka, Saitama, Japan

    Study coordinator · +81-42-984-4111

  • Cancer Institute Hospital of JFCR ( Site 1614), Koto, Tokyo, Japan

    Study coordinator · +81-3-3520-0111

  • Kagoshima City Hospital ( Site 1613), Kagoshima, Japan

    Study coordinator · +81-99-230-7000

  • Niigata Cancer Center Hospital ( Site 1608), Niigata, Japan

    Study coordinator · +81-25-266-5111

  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 1604), Osaka, Japan

    Study coordinator · +81-6-6945-1181

  • Stavanger Universitetssjukehus ( Site 2002), Stavanger, Rogaland, Norway

    Study coordinator · 4751518000

  • Sorlandet Sykehus Kristiansand ( Site 2003), Kristiansand, Vest-Agder, Norway

    Study coordinator · +4738073070

  • Oslo University Hospital ( Site 2001), Oslo, Norway

    Study coordinator · +47-48512384

  • Uniwersytecki Szpital Kliniczny w Poznaniu-Oddzial Ginekologii Onkologicznej ( Site 2106), Poznan, Greater Poland Voivodeship, Poland

    Study coordinator · +48618549014

  • Wielkopolskie Centrum Onkologii im. Marii Skłodowskiej-Curie ( Site 2105), Poznan, Greater Poland Voivodeship, Poland

    Study coordinator · +48 61 8850 557

  • Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2102), Siedlce, Masovian Voivodeship, Poland

    Study coordinator · +48256403485

  • Bialostockie Centrum Onkologii ( Site 2104), Bialystok, Podlaskie Voivodeship, Poland

    Study coordinator · +48856646732

  • Severance Hospital ( Site 2302), Seodaemun-Gu, Seoul, South Korea

    Study coordinator · +82222277969

  • Keimyung University Dongsan Hospital ( Site 2304), Daegu, Taegu-Kwangyokshi, South Korea

    Study coordinator · +82532586671

  • Seoul National University Hospital ( Site 2301), Seoul, South Korea

    Study coordinator · +82260724984

  • Asan Medical Center ( Site 2305), Seoul, South Korea

    Study coordinator · +82230103640

  • Samsung Medical Center ( Site 2303), Seoul, South Korea

    Study coordinator · +82234101382

  • Institut Català d'Oncologia (ICO) - Girona ( Site 2402), Girona, Gerona, Spain

    Study coordinator · +34972225834

  • Complejo Hospitalario Universitario A Coruna ( Site 2412), A Coruña, La Coruna, Spain

    Study coordinator · 34981178353

  • Clinica Universidad de Navarra ( Site 2407), Madrid, Madrid, Comunidad de, Spain

    Study coordinator · +34913531920/ 7513

  • Instituto Valenciano de Oncologia - IVO ( Site 2411), Valencia, Valenciana, Comunitat, Spain

    Study coordinator · +34961114229

  • Hospital Clinic I Provincial de Barcelona ( Site 2409), Barcelona, Spain

    Study coordinator · +34932275402

  • ICO L Hospitalet ( Site 2408), Barcelona, Spain

    Study coordinator · +34932607744

  • Hospital Clinico San Carlos... ( Site 2410), Madrid, Spain

    Study coordinator · 34913303000 x484811

  • Karolinska Universitetssjukhuset Solna ( Site 2502), Stockholm, Stockholm County, Sweden

    Study coordinator · +460812370000

  • Inselspital Bern ( Site 3504), Bern, Canton of Bern, Switzerland

    Study coordinator · 41316326416

  • Ospedale Regionale Bellinzona e Valli ( Site 3501), Bellinzona, Canton Ticino, Switzerland

    Study coordinator · 41918118194

  • Kantonsspital Graubünden ( Site 3503), Chur, Kanton Graubünden, Switzerland

    Study coordinator · +41 81 256 6646

  • Hôpitaux Universitaires de Genève (HUG) ( Site 3502), Geneva, Switzerland

    Study coordinator · +41795534976

  • Taichung Veterans General Hospital ( Site 2603), Taichung, Taiwan

    Study coordinator · 886-4-23592525x5822

  • National Cheng Kung University Hospital ( Site 2602), Tainan, Taiwan

    Study coordinator · +8862353535

  • National Taiwan University Hospital ( Site 2601), Taipei, Taiwan

    Study coordinator · 886-223123456x271563

  • Mackay Memorial Hospital ( Site 2604), Taipei, Taiwan

    Study coordinator · +886225433535

  • Linkou Chang Gung Memorial Hospital ( Site 2605), Taoyuan, Taiwan

    Study coordinator · 886-33281200x8258

  • Faculty of Medicine - Khon Kaen University ( Site 3403), Muang, Changwat Khon Kaen, Thailand

    Study coordinator · +6643348382
Study leads

  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)